Several leading cancer research centres have partnered to launch Juno Therapeutics, a cancer immunotherapy startup, which has received one of the largest series A rounds in history. Seattle-based Fred Hutchinson Cancer Research Centre and the Seattle Children’s Research Institute partnered on the New York City-based Memorial Sloan-Kettering Cancer Centre (MSKCC) to launch the venture. Investors…
Juno brings big guns against cancer
Dec 5, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024